PET imaging of adenosine A1 receptors with 11C-MPDX as an indicator of severe cerebral ischemic insult

Journal of Nuclear Medicine

Volumn 44, Issue 11, 2003, Pages 1839-1844

  Nariai, Tadashi ^a   Shimada, Yuhei ^b   Ishiwata, Kiichi ^c   Nagaoka, Tsukasa ^a   Shimada, Junichi ^d   Kuroiwa, Toshihiko ^a   Ono, Ken Ichiro ^b   Ohno, Kikuo ^a   Hirakawa, Kimiyoshi ^a   Senda, Michio ^c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^d KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Adenosine A1 receptor; Cat; Cerebral ischemia; Glucose metabolism; Middle cerebral artery occlusion; PET

Indexed keywords

8 DICYCLOPROPYLMETHYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; BENZODIAZEPINE RECEPTOR; CARBON 11; FLUMAZENIL; FLUORINE 18; GLUCOSE; INDICATOR; OXYGEN 15; WATER; 1 METHYL 8 DICYCLOPROPYLMETHYL 1 METHYL 3 PROPYLXANTHINE; 1-METHYL-8-DICYCLOPROPYLMETHYL-1-METHYL-3-PROPYLXANTHINE; CARBON; DIAGNOSTIC AGENT; XANTHINE DERIVATIVE;

ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CARBON NUCLEAR MAGNETIC RESONANCE; CAT; CONTROLLED STUDY; DISEASE SEVERITY; GLUCOSE METABOLISM; MEASUREMENT; MIDDLE CEREBRAL ARTERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; SURVIVAL RATE; ANIMAL; BRAIN CIRCULATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METABOLISM; SCINTISCANNING;

ANIMALS; BRAIN ISCHEMIA; CARBON RADIOISOTOPES; CATS; CEREBROVASCULAR CIRCULATION; MAGNETIC RESONANCE IMAGING; RECEPTOR, ADENOSINE A1; TOMOGRAPHY, EMISSION-COMPUTED; XANTHINES;

EID: 0642345822     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB. Neuroprotective role of adenosine in cerebral ischaemia Trends Pharmacol Sci 1992;13:439-445
2. Sweeney MI Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity Neurosci Biobehav Rev 1997;21:207-217
3. von Lubitz DK Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? Eur J Pharmacol. 1999;371:85-102.
4. Pearson T, Nuritova F, Caldwell D, Dale N, Frenguelli BG A depletable pool of adenosine in area CA1 of the rat hippocampus. J Neurosci. 2001;21:2298-2307.
5. Furuta R, Ishiwata K, Kiyosawa M, et al Carbon-11-labeled KF15372: a potential central nervous system adenosine A1 receptor ligand. J Nucl Med. 1996;37:1203-1207.
6. Noguchi J, Ishiwata K, Furuta R, et al. Evaluation of carbon-11 labeled KF15372 and its ethyl and methyl derivatives as a potential CNS adenosine A1 receptor ligand. Nucl Med Biol. 1997;24:53-59.
7. 11C-Labeled KF18446: a potential central nervous system adenosine A2a receptor ligand. J Nucl Med. 2000;41:345-354.
8. Noguchi J, Ishiwata K, Wakabayashi S, et al. Evaluation of carbon-11-labeled KF17837: a potential CNS adenosine A2a receptor ligand. J Nucl Med. 1998;39:498-503.
9. Wakabayashi S, Nariai T, Ishiwata K, et al. A PET study of adenosine A1 receptor in anesthetized monkey brain. Nucl Med Biol. 2000;27:401-406
10. 11C]MPDX. Nucl Med Biol. 2002;29:29-37.
11. 11C]KF21562. Nucl Med Biol. 2001;28:281-285.
12. 11C]MPDX for mapping adenosine A1 receptors by positron emission tomography. Ann Nucl Med. 2002,16:377-382
13. Watanabe M, Uchida H, Okada H, et al. A high resolution PET for animal studies. IEEE Trans Med Imaging. 1992;1992:577-580
14. Sakiyama Y, Sato A, Senda M, Ishiwata K, Toyama H, Schmidt RF. Positron emission tomography reveals changes in global and regional cerebral blood flow during noxious stimulation of normal and inflamed elbow joints in anesthetized cats Exp Brain Res. 1998;118:439-446.
15. 11C]flumazenil. Am J Vet Res. 2003;64:999-1002.
16. Shimada Y, Uemura K, Ardekani BA, et al. Application of PET-MRI registration techniques to cat brain imaging. J Neurosci Methods. 2000;101:1-7.
17. Hosli E, Hosli L. Receptors for neurotransmitters on astrocytes in the mammalian central nervous system. Prog Neurobiol 1993;40:477-506.
18. Goodman RR, Kuhar MJ, Hester L, Snyder SH Adenosine receptors: autoradiographic evidence for their location on axon terminals of excitatory neurons Science. 1983;220:967-969.
19. Matus A, Pehling G, Wilkinson D. Gamma-aminobutyric acid receptors in brain postsynaptic densities. J Neurobiol. 1981;12:67-73.
20. 3H]flumazenil in deafferented visual areas of the adult mouse brain. Synapse. 1994;18:79-85.
21. Lassen NA. The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localised within the brain. Lancet. 1966;2:1113-1115
22. 14C] deoxyglucose technique. J Cereb Blood Flow Metab. 1992;12:70-77.
23. Lenzi GL, Frackowiak RS, Jones T. Cerebral oxygen metabolism and blood flow in human cerebral ischemic infarction. J Cereb Blood Flow Metab. 1982;2:321-335.
24. Heiss WD, Graf R, Fujita T, et al. Early detection of irreversibly damaged ischemic tissue by flumazenil positron emission tomography in cats. Stroke. 1997;28:2045-2051.
25. 2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke. 2000;31:366-369.
26. Hagberg H, Andersson P, Lacarewicz J, Jacobson I, Butcher S, Sandberg M. Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J Neurochem. 1987;49:227-231
27. Melani A, Pantoni L, Corsi C, et al. Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage. Stroke 1999;30:2448-2454
28. Matsumoto K, Graf R, Rosner G, Shimada N, Heiss WD. Flow thresholds for extracellular purine catabolite elevation in cat focal ischemia Brain Res 1992;579:309-314.
29. Koepp MJ, Gunn RN, Lawrence AD, et al. Evidence for Striatal dopamine release during a video game. Nature. 1998;393:266-268.
30. Erdemli G, Xu YZ, Krnjevic K. Potassium conductance causing hyperpolarization of CA1 hippocampal neurons during hypoxia. J Neurophysiol. 1998;80:2378-2390.
31. Fowler JC. Adenosine antagonists delay hypoxia-induced depression of neuronal activity in hippocampal brain slice. Brain Res. 1989;490:378-384.
32. Katchman AN, Hershkowitz N Adenosine antagonists prevent hypoxia-induced depression of excitatory but not inhibitory synaptic currents. Neurosci Lett 1993;159:123-126.
33. Pearson T, Frenguelli BG. Volume-regulated anion channels do not contribute extracellular adenosine during the hypoxic depression of excitatory synaptic transmission in area CA1 of rat hippocampus. Eur J Neurosci. 2000;12:3064-3066.
34. Phillis JW, O'Regan MH. Deoxycoformycin antagonizes ischemia-induced neuronal degeneration. Brain Res Bull. 1989;22:537-540
35. Gidday JM, Fitzgibbons JC, Shah AR, Kraujalis MJ, Park TS. Reduction in cerebral ischemic injury in the newborn rat by potentiation of endogenous adenosine. Pediatr Res 1995;38:306-311.
36. de Mendonca A, Sebastiao AM, Ribeiro JA. Adenosine: does it have a neuroprotective role after all? Brain Res Brain Res Rev. 2000;33:258-274.
37. Nilsson P, Hillered L, Ponten U, Ungerstedt U. Changes in cortical extracellular levels of energy-related metabolites and amino acids following concussive brain injury in rats. J Cereb Blood Flow Metab. 1990,10:631-637.
38. Headrick JP, Bendall MR, Faden AI, Vink R. Dissociation of adenosine levels from bioenergetic state in experimental brain trauma: potential role in secondary injury. J Cereb Blood Flow Metab. 1994;14:853-861.
39. Dunwiddie TV. Adenosine and suppression of seizures. Adv Neurol. 1999;79:1001-1010.